Abstract

High dose-rate brachytherapy is a treatment technique for gynecologic cancers where intracavitary applicators are placed within the patient’s pelvic cavity. To ensure accurate radiation delivery, localization of the applicator at the time of insertion is vital. This study proposes a novel method for acquiring, registering, and fusing three-dimensional (3D) trans-abdominal and 3D trans-rectal ultrasound (US) images for visualization of the pelvic anatomy and applicators during gynecologic brachytherapy. The workflow was validated using custom multi-modal pelvic phantoms and demonstrated during two patient procedures. Experiments were performed for three types of intracavitary applicators: ring-and-tandem, ring-and-tandem with interstitial needles, and tandem-and-ovoids. Fused 3D US images were registered to magnetic resonance (MR) and computed tomography (CT) images for validation. The target registration error (TRE) and fiducial localization error (FLE) were calculated to quantify the accuracy of our fusion technique. For both phantom and patient images, TRE and FLE across all modality registrations (3D US versus MR or CT) resulted in mean ± standard deviation of 4.01 ± 1.01 mm and 0.43 ± 0.24 mm, respectively. This work indicates proof of concept for conducting further clinical studies leveraging 3D US imaging as an accurate, accessible alternative to advanced modalities for localizing brachytherapy applicators.

Details

Title
Three-dimensional trans-rectal and trans-abdominal ultrasound image fusion for the guidance of gynecologic brachytherapy procedures: a proof of concept study
Author
Trumpour, Tiana 1 ; du Toit, Carla 2 ; van Gaalen, Alissa 3 ; Park, Claire K. S. 4 ; Rodgers, Jessica R. 5 ; Mendez, Lucas C. 6 ; Surry, Kathleen 7 ; Fenster, Aaron 1 

 Western University, Department of Medical Biophysics, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Robarts Research Institute, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884) 
 Robarts Research Institute, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884) 
 University of Waterloo, Department of Physics and Astronomy, Waterloo, Canada (GRID:grid.46078.3d) (ISNI:0000 0000 8644 1405) 
 Harvard Medical School, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Department of Radiation Oncology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 University of Manitoba, Department of Physics and Astronomy, Winnipeg, Canada (GRID:grid.21613.37) (ISNI:0000 0004 1936 9609) 
 Verspeeten Family Cancer Centre, London, Canada (GRID:grid.21613.37) 
 Western University, Department of Medical Biophysics, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Verspeeten Family Cancer Centre, London, Canada (GRID:grid.39381.30); Western University, Department of Oncology, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884) 
Pages
18459
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3090749716
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.